Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Cell Reports
|
October 5, 2024
NBAtlas: A harmonized single-cell transcriptomic reference atlas of human neuroblastoma tumors
Noah Bonine, Vittorio Zanzani, Annelies Van Hemelryk, et al.
Science Translational Medicine
|
July 6, 2012
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice
Lukas C Heukamp, Theresa Thor, Alexander Schramm, et al.
The Lancet. Child & Adolescent Health
|
April 13, 2026
Bedside model-informed precision dosing of vancomycin in severely ill neonates and children in Belgium (the BENEFICIAL trial): a multicentre, randomised controlled trial
Pieter A De Cock, Roos Colman, Anne Smits, et al.
Cancer
|
February 11, 2025
A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma
Steven G DuBois, Chitose Ogawa, Lucas Moreno, et al.
JCO Precision Oncology
|
January 18, 2023
Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma
Nathalie S M Lak, Lieke M J van Zogchel, Lily Zappeij-Kannegieter, et al.
Oncotarget
|
December 10, 2015
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
Anneleen Decock, Maté Ongenaert, Robrecht Cannoodt, et al.
The Lancet. Digital Health
|
October 25, 2024
Unleashing the strengths of unlabelled data in deep learning-assisted pan-cancer abdominal organ quantification: the FLARE22 challenge
Jun Ma, Yao Zhang, Song Gu, et al.
NPJ Digital Medicine
|
May 16, 2025
The DRAGON benchmark for clinical NLP
Joeran S Bosma, Koen Dercksen, Luc Builtjes, et al.
Oncogene
|
December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expression
Shana Claeys, Geertrui Denecker, Kaat Durinck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2021
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples
Ruben Van Paemel, Charlotte Vandeputte, Lennart Raman, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Cell Reports
|
October 5, 2024
NBAtlas: A harmonized single-cell transcriptomic reference atlas of human neuroblastoma tumors
Noah Bonine, Vittorio Zanzani, Annelies Van Hemelryk, et al.
Science Translational Medicine
|
July 6, 2012
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice
Lukas C Heukamp, Theresa Thor, Alexander Schramm, et al.
The Lancet. Child & Adolescent Health
|
April 13, 2026
Bedside model-informed precision dosing of vancomycin in severely ill neonates and children in Belgium (the BENEFICIAL trial): a multicentre, randomised controlled trial
Pieter A De Cock, Roos Colman, Anne Smits, et al.
Cancer
|
February 11, 2025
A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma
Steven G DuBois, Chitose Ogawa, Lucas Moreno, et al.
JCO Precision Oncology
|
January 18, 2023
Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma
Nathalie S M Lak, Lieke M J van Zogchel, Lily Zappeij-Kannegieter, et al.
Oncotarget
|
December 10, 2015
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
Anneleen Decock, Maté Ongenaert, Robrecht Cannoodt, et al.
The Lancet. Digital Health
|
October 25, 2024
Unleashing the strengths of unlabelled data in deep learning-assisted pan-cancer abdominal organ quantification: the FLARE22 challenge
Jun Ma, Yao Zhang, Song Gu, et al.
NPJ Digital Medicine
|
May 16, 2025
The DRAGON benchmark for clinical NLP
Joeran S Bosma, Koen Dercksen, Luc Builtjes, et al.
Oncogene
|
December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expression
Shana Claeys, Geertrui Denecker, Kaat Durinck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2021
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples
Ruben Van Paemel, Charlotte Vandeputte, Lennart Raman, et al.
Page
of 7